Tolerability, acceptability, and reproducibility of topical STAR particles in human subjects.
Journal Information
Full Title: Bioeng Transl Med
Abbreviation: Bioeng Transl Med
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Engineering, Biomedical
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"data s1: supporting information click here for additional data file."
"CONFLICT OF INTEREST STATEMENT This conflict of interest has been disclosed and is managed by Georgia Institute of Technology."
"We thank Richard Schafer for technical support with laser micromachining and Donna Bondy for administrative support. This work was supported by a grant from the Georgia Research Alliance. Mark R. Prausnitz and Andrew R. Tadros have a financial interest in the STAR particle technology discussed here, as an inventor of licensed patents and a consultant and co‐founder of companies (Aldena Therapeutics, Vimela Therapeutics, Microstar Biotech) associated with STAR particles."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025